Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by CCAbbott888on Apr 24, 2019 12:13pm

217 Views

Post# 29664404

RE:RE:RE:RE:Eligibility for Right Offering

CCAbbott888 wrote:

Whyme16 wrote: So, does that mean ONLY purchases to the end of April 22nd prior to completion of refinancing transaction announcement made yesterday April 23rd are eligible for right offering?

Whyme 16, no it does not mean that. It is totally unclear which date that the company will set as the Record date at this point. They could still set it on any day. They are not clarifying that at the point.

Correction: at *this point.

The company is NOT clarifying at this point which date they will set as the Record date.

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price